Home > Insider Trading > Filing (0001544982-13-000002)

Filing Details

Accession Number:: 0001544982-13-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-26 17:21:36
Reporting Period:: 2013-02-22

Filing Date:: 2013-02-26
Accepted Time:: 2013-02-26 17:21:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1091596	Cytomedix Inc	CMXI	Surgical & Medical Instruments & Apparatus (3841)	232958959

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1435388	Jefferson B. Clark	790 Se Cary Parkway Suite 204 Cary NC 27511	No	No	Yes	Yes
1544982	Aldagen Holdings, Llc	C/O Thomas A. Allen, Esq. 4101 Lake Boone Trail, Ste 300 Raleigh NC 27607	No	No	Yes	Yes
1545337	W William Brooke	1210 East Cary Street Suite 400 Richmond VA 23219	No	No	Yes	Yes
1546305	Kathryne Carr	315 Old Ivy Way Charlottesville VA 22903	No	No	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-02-22	22,308	$0.55	108,830	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2013-02-22	32,238	$0.55	157,276	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2013-02-22	90,909	$0.55	175,533	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2013-02-22	90,909	$0.55	429,404	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2013-02-22	18,182	$0.55	60,494	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2013-02-22	27,273	$0.55	39,967	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	15,616	$0.00	15,616	$0.75
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	22,567	$0.00	22,567	$0.75
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	63,636	$0.00	63,636	$0.75
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	63,636	$0.00	63,636	$0.75
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	12,727	$0.00	12,727	$0.75
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	19,091	$0.00	19,091	$0.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,616	2013-02-22	2018-02-21	No	4	P	Indirect
22,567	2013-02-22	2018-02-21	No	4	P	Indirect
63,636	2013-02-22	2018-02-21	No	4	P	Indirect
63,636	2013-02-22	2018-02-21	No	4	P	Indirect
12,727	2013-02-22	2018-02-21	No	4	P	Indirect
19,091	2013-02-22	2018-02-21	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,982,145	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Warrant (right to buy)	$1.42	2014-12-31	61,584	61,584	Indirect
Common Stock	Warrant (right to buy)	$1.42	2014-12-31	89,029	89,029	Indirect
Common Stock	Warrant (right to buy)	$1.42	2014-12-31	238,315	238,315	Indirect
Common Stock	Warrant (right to buy)	$1.42	2014-12-31	12,168	12,168	Indirect
Common Stock	Warrant (right to buy)	$1.42	2014-12-31	12,695	12,695	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2014-12-31	61,584	61,584	Indirect
2014-12-31	89,029	89,029	Indirect
2014-12-31	238,315	238,315	Indirect
2014-12-31	12,168	12,168	Indirect
2014-12-31	12,695	12,695	Indirect

Footnotes

The shares of common stock and common stock warrants were acquired on February 22, 2013, in a registered offering of the Issuer's securities pursuant to the effective registration statement on Form S-3 (File No. 333-183704). The Reportable Securities in the above-referenced offering were sold in units, at the price per unit of $0.55, with each unit consisting of one share of common stock together with a warrant to purchase 0.7 of a share of common stock.
The reportable securities are owned directly by Harbinger/Aurora Venture Fund, L.L.C. ("Harbinger Venture Fund"), and indirectly by Harbinger/Aurora Ventures, L.L.C. ("Harbinger Ventures LLC"), as the managing member of Harbinger Venture Fund. Mr. Clark is the president of Harbinger Ventures LLC and a managing member of Holdings. Harbinger Ventures LLC and Harbinger Venture Fund may share voting and dispositive power over the shares directly held by Harbinger Venture Fund. Mr. Clark disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by Harbinger/Aurora QP Venture Fund, L.L.C. ("Harbinger QP"), and indirectly by Harbinger Ventures LLC, as the managing member of Harbinger QP. Harbinger Ventures LLC and Harbinger QP may share voting and dispositive power over the shares directly held by Harbinger QP. Mr. Clark disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by Harbert Venture Partners (Annex Fund), L.L.C. ("Harbert Venture Fund"), indirectly by Harbert Venture Partners MM, LLC ("Harbert Venture Partners LLC"), as the sole managing member of Harbert Venture Fund, and indirectly by Will Brooke, as managing partner of Harbert Venture Partners LLC. Mr. Brooke is a managing member of Holdings. Harbert Venture Fund, Harbert Venture Partners LLC, and Mr. Brooke may share voting and dispositive power over the shares directly held by Harbert Venture Fund. Mr. Brooke disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by ALD Co-Investor, LLC ("ALD"), indirectly by Harbert Venture Partners LLC, as the sole managing member of ALD, and indirectly by Mr. Brooke, as managing partner of Harbert Venture Partners LLC. ALD, Harbert Venture Partners LLC, and Mr. Brooke may share voting and dispositive power over the shares directly held by ALD. Mr. Brooke disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by Aurora Enrichment Fund, L.L.C. ("Aurora"), and indirectly by Aurora Enrichment Management Company, L.L.C. ("Aurora Management Co"), as the managing member of Aurora, and each of the individual managing members of Aurora Management Co. The individual managing members (each an "Aurora Manager" and collectively, the "Aurora Managers") of Aurora Management Co are Messrs. Clark and Albert. Mr. Clark is the manager of Aurora Management Co and a managing member of Holdings. Aurora Management Co, Aurora, and the Aurora Managers may share voting and dispositive power over the shares directly held by Aurora. Each Aurora Manager disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by Tall Oaks Capital Investments, LLC ("Tall Oaks"), and indirectly by Tall Oaks Capital Partners, LLC ("Tall Oaks Partners"), as the managing member of Tall Oaks, and each of the individual managing directors of Tall Oaks Partners. The individual managing directors (each a "Tall Oaks Manager" and collectively, the "Tall Oaks Managers") of Tall Oaks Partners are James B. Farinholt, A. Reenst Lesemann, Victor Dandridge, III, Ms. Carr, Hiram Ewald and Colin Rolph. Tall Oaks Partners, Tall Oaks and the Tall Oaks Managers may share voting and dispositive power over the shares directly held by Tall Oaks. Each Tall Oaks Manager disclaims beneficial ownership of these securities and this report is not an admission that he or she is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his or her pecuniary interest therein.
The reportable securities are owned directly by Holdings. The shares directly held by Holdings are indirectly held by the individual managing members of Holdings (each a "Holdings Managing Member" and collectively, the "Holdings Managing Members"). The Holdings Managing Members are B. Jefferson Clark, William Brooke and Kathryne Carr. The Holdings Managing Members may share voting and dispositive power over the shares directly held by Holdings. Each Holdings Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any Holdings Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his or her pecuniary interest therein.
30% of the warrant is exercisable on February 8, 2012, and the remaining balance of the warrant is exercisable upon the occurrence of the Third Post-Closing Issuance (as defined and set forth in Section 2.4 of the Exchange and Purchase Agreement).